Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Recruiting1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT04482933Phase 2Withdrawn
HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma
Anaplastic Astrocytoma of BrainAnaplastic GliomaGiant Cell Glioblastoma+5 more
PrincipalinvestigatorStart date: 2025-09-01
NCT03911388Phase 1Recruiting
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
AstrocytomaAstrocytoma, CerebellarBrain Diseases+30 more
PrincipalinvestigatorStart date: 2019-09-12

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Kevin A camphausen, M.D.

National Cancer Institute (NCI)

Related
17 trials

Shared therapeutic areas:

Brain NeoplasmsGlioblastoma MultiformeNeoplasms+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

NeoplasmsBrain NeoplasmsNeoplasm Metastasis
Similarity Score2%

David S Schrump, M.D.

National Cancer Institute (NCI)

Related
21 trials

Shared therapeutic areas:

Neoplasms, Germ Cell and EmbryonalNeoplasm MetastasisNeoplasms

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Brain NeoplasmsNeoplasms, Nerve Tissue

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

High Grade GliomaNeuroectodermal Tumors, Primitive
Similarity Score2%

E-mail: ClinicalTrials@ ImClone.com

Eli Lilly and Company

Related
22 trials

Shared therapeutic areas:

Neoplasm MetastasisNeoplasms
Similarity Score2%

Richard W Childs, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
15 trials

Shared therapeutic areas:

Neoplasm MetastasisNeoplasms
Similarity Score2%

Avindra Nath, M.D.

National Institute of Neurological Disorders and Stroke (NINDS)

Related
14 trials

Shared therapeutic areas:

Nervous System DiseasesBrain Diseases
Similarity Score2%

Robert B Innis, M.D.

National Institute of Mental Health (NIMH)

Related
35 trials

Shared therapeutic areas:

Brain DiseasesNervous System Diseases
Similarity Score2%

Edward G. Shaw, MD

Wake Forest University Health Sciences

Related
12 trials

Shared therapeutic areas:

Brain NeoplasmsNervous System Neoplasms

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04482933Phase 2PrincipalInvestigator

HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma

Anaplastic Astrocytoma of BrainAnaplastic GliomaGiant Cell Glioblastoma+5 more
Withdrawn
NCT03911388Phase 1PrincipalInvestigator

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

AstrocytomaAstrocytoma, CerebellarBrain Diseases+30 more
Recruiting

All 2 trials loaded